SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors rally behind the stock's potential for oncology breakthroughs, fueled by optimism over global expansion efforts and a growing list of regulatory catalysts. While some community members remain focused on the company's long-term commercial execution and potential for a short squeeze, others are actively debating the impact of recent insider selling and the company's overall regulatory strategy.

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending as investors debate whether the stock is a deep-value opportunity approaching a structural bottom or a permanent laggard suffering from eroded market share and ineffective leadership. The community is intensely focused on the company's aggressive share buyback program and the persistent lack of upward price momentum, with many users speculating about potential buyout catalysts or a strategic shift in the digital payments landscape.

ZIM Integrated Shipping Services Ltd. engages in the provision of shipping and logistics services. It offers shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. The company was founded on June 7, 1945 and is headquartered in Haifa, Israel.

Zim Integrated Shipping Services Ltd

ZIM is trending as investors weigh a $35 cash acquisition by Hapag-Lloyd against a rival $37.50 offer from the Israeli-led Sakal Group, sparking intense debate over whether the buyout will proceed or be restructured. The community is actively discussing the stock's significant dividend potential and fundamental strength, fueled by surging freight rates and geopolitical tensions in major shipping corridors.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors bet on an imminent buyout and major trial readouts, with the community closely tracking institutional accumulation and a massive short interest dynamic. Traders are actively debating whether these factors signal a potential short squeeze or a transformative acquisition for the company's oncology pipeline.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as the community debates the implications of its recent $875.8 million acquisition of DZYNE Technologies and a subsequent upgrade to its 2026 revenue guidance. While some investors remain concerned about equity dilution and share price volatility, others are highlighting the company's expanding backlog and strategic positioning within the autonomous defense sector as reasons for long-term optimism.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is drawing significant investor attention as it nears a high-stakes FDA decision for its lead kidney disease drug, with the community actively debating potential upside and strategies for navigating the upcoming PDUFA date. Discussions are heavily focused on the stock's clinical differentiation, the potential for institutional buying or a strategic buyout, and sentiment surrounding the company's competitive positioning in the IgA nephropathy market.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors focus on its potential as a key data licensing provider for AI models, with the community actively debating whether the platform's valuation is driven by sustainable fundamental growth or short-term momentum. Traders are closely monitoring the stock's consolidation patterns near the 200-day moving average while analyzing potential data-related partnerships as a major catalyst.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors debate the sustainability of the optical networking sector following a volatile period of repricing and conflicting industry reports regarding co-packaged optics adoption. While some community members highlight long-term structural demand from hyperscalers and institutional support as key catalysts, others express caution over stretched valuations and recent insider selling.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors weigh strong box office sentiment from recent franchise releases against persistent concerns regarding linear TV valuation and corporate leadership. The community remains deeply divided, balancing optimism for an operational turnaround and streaming profitability against long-term frustration over stagnant price action and social-political discourse.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is gaining momentum as investors closely watch its ongoing commercial success and pipeline developments, with many in the community increasingly discussing the potential for an acquisition given the company's strong revenue growth. While the stock has seen significant appreciation, discussions remain focused on the potential for a short squeeze as market participants debate whether long-term value will be unlocked through sustained independent growth or a strategic buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
